Archit Life Science Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 7.00 Cr
- Company Age 2 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 49.25 Cr
About Archit Life Science
Archit Life Science Limited (ALSL) is a Public Limited Indian Non-Government Company incorporated in India on 02 September 2022 (Two years and five months 8 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.00 Cr.
The company currently has active open charges totaling ₹49.25 Cr.
Kandarp Amin, Archit Amin, and Suchit Amin serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290GJ2022PLC135184
-
Company No.
135184
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
02 Sep 2022
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Archit Life Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kandarp Amin
|
Director | 02-Sep-2022 | Current |
|
Archit Amin
|
Director | 02-Sep-2022 | Current |
|
Suchit Amin
|
Director | 02-Sep-2022 | Current |
Financial Performance of Archit Life Science.
Enhance accessibility to Archit Life Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Archit Life Science?
In 2023, Archit Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Dangee Dums LimitedSuchit Amin is a mutual person
-
Adonis Lifecare Private LimitedArchit Amin and Suchit Amin are mutual person
-
Rajpath Club LimitedKandarp Amin is a mutual person
-
Archit Organosys LimitedKandarp Amin and Archit Amin are mutual person
Charges (Loans)
₹49.25 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 49.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Dec 2023 | Others | ₹49.25 Cr | Open |
How Many Employees Work at Archit Life Science?
Archit Life Science has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Archit Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Archit Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.